<p>Aveanna Healthcare（納斯達克代碼：AVAH - 獲取免費報告）於週四公佈了季度財報。該公司報告本季度每股收益（EPS）為 0.15 美元，超出市場共識預期的 0.07 美元，超出幅度為 0.08 美元，FiscalAI 報道。該公司本季度的收入為 6.2194 億美元，而分析師預期為 5.7857 億美元。Aveanna Healthcare 的淨利潤率為 3.29%，股本回報率為負 103.46%。Aveanna Healthcare 更新了其 2025 財年的每股收益指引。</p>
<p>獲取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
<h2>Aveanna Healthcare 價格表現</h2>
<p>週五，AVAH 的交易價格上漲 0.12 美元，達到 8.75 美元。該公司的交易量為 1,381,278 股，而其平均交易量為 1,771,923 股。該公司的市值為 18.3 億美元，市盈率為 24.31，貝塔值為 2.04。Aveanna Healthcare 的 12 個月低點為 3.67 美元，12 個月高點為 10.32 美元。該公司的 50 日移動平均價格為 8.86 美元，200 日移動平均價格為 6.48 美元。</p>
<h2>分析師評級調整</h2>
<p>多家股票分析師最近對該公司進行了評估。瑞銀集團將 Aveanna Healthcare 的目標價從 9.00 美元上調至 9.50 美元，並在週五的研究報告中給予該公司 “中性” 評級。雷蒙德·詹姆斯金融公司將 Aveanna Healthcare 的評級從 “市場表現” 上調至 “跑贏大盤”，並在 8 月 11 日的研究報告中設定了 9.00 美元的目標價。韋斯評級在 10 月 8 日的研究報告中重新發布了對 Aveanna Healthcare 股票的 “持有（c）” 評級。巴克萊將 Aveanna Healthcare 的評級從 “等權重” 上調至 “超配”，並在 8 月 19 日的報告中將該股票的目標價從 5.50 美元上調至 9.50 美元。最後，加拿大皇家銀行在 10 月 24 日的報告中將 Aveanna Healthcare 的目標價從 8.00 美元上調至 10.00 美元，並給予該公司 “行業表現” 評級。三位股票研究分析師對該股票給予了買入評級，六位分析師給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “持有”，共識目標價為 10.07 美元。</p>
<p><strong>閲讀我們對 Aveanna Healthcare 的最新分析</strong></p>
<h2>Aveanna Healthcare 的內部活動</h2>
<p>在相關消息中，主要股東 Robert M. Williams, Jr.於 10 月 24 日週五出售了 1,500,000 股公司的股票。股票以平均價格 9.00 美元出售，總價值為 13,500,000.00 美元。交易完成後，該內部人士直接持有 362,746 股公司的股票，估值約為 3,264,714 美元。這代表其持股比例減少了 80.53%。該出售在向證券交易委員會提交的文件中披露，文件可通過此鏈接訪問。此外，主要股東 Paul R. Vigano 於 10 月 24 日週五出售了 1,500,000 股股票。該股票以平均價格 9.00 美元出售，總價值為 13,500,000.00 美元。交易完成後，該內部人士持有 362,746 股公司的股票，估值約為 3,264,714 美元。這筆交易代表其持股比例減少了 80.53%。該出售的披露信息可在 SEC 文件中找到。在過去的九十天裏，內部人士已出售 32,597,968 股公司股票，價值為 293,381,712 美元。7.80% 的股票由公司內部人士持有。</p>
<h2>機構投資者對 Aveanna Healthcare 的看法</h2>
<p>幾家對沖基金和其他機構投資者最近增加或減少了對 AVAH 的持股。先鋒集團在第三季度將其在 Aveanna Healthcare 的股份增加了 34.7%。先鋒集團目前持有 4,041,659 股公司股票，價值為 35,850,000 美元，此前在上個季度又購買了 1,041,324 股。Squarepoint Ops LLC 在第二季度將其在 Aveanna Healthcare 的持股增加了 207.0%。Squarepoint Ops LLC 目前持有 479,977 股公司股票，價值為 2,510,000 美元，此前在上個季度又購買了 323,656 股。Qube Research &amp; Technologies Ltd 在第二季度將其在 Aveanna Healthcare 的持股增加了 92.4%。Qube Research &amp; Technologies Ltd 目前持有 437,838 股公司股票，價值為 2,290,000 美元，此前在上個季度又購買了 210,288 股。Lazard Asset Management LLC 在第二季度收購了 Aveanna Healthcare 的新股份，價值約為 791,000 美元。最後，Ameriprise Financial Inc.在第二季度將其在 Aveanna Healthcare 的持股增加了 168.0%。Ameriprise Financial Inc.目前持有 145,982 股公司股票，價值為 763,000 美元，此前在上個季度又購買了 91,508 股。87.96% 的股票目前由機構投資者和對沖基金持有。</p>
<h2>Aveanna Healthcare 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Aveanna Healthcare Holdings Inc 是一家多元化的居家護理平台公司，在美國提供兒童和成人醫療服務。其以患者為中心的護理交付平台使患者能夠留在家中，減少對高成本護理環境（如醫院或專業護理機構）的過度使用。</p>
<h2>推薦閲讀</h2>
<ul>
<li>我們更看好的五隻股票超過 Aveanna Healthcare</li>
<li>商業服務股票投資</li>
<li>分析師認為 e.l.f.的拋售是一個良好的買入時機</li>
<li>關於 Markup 計算器</li>
<li>T-Mobile 是最被低估的大型股——是買入時機嗎？</li>
<li>2022-2025 年股市假期 - 紐約證券交易所和納斯達克將何時關閉</li>
<li>高通財報讓華爾街感到驚訝——第四季度可能會帶來什麼</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Aveanna Healthcare 嗎？</h2>
<p>在考慮 Aveanna Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄向客户推薦在更廣泛的市場注意到之前購買……而 Aveanna Healthcare 並不在名單上。</p>
<p>雖然 Aveanna Healthcare 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

AVAH

<p>Aveanna Healthcare（納斯達克代碼：AVAH）報告本季度每股收益為 0.15 美元，超出預期的 0.07 美元。收入達到 6.2194 億美元，超過預期的 5.7857 億美元。該公司的股本回報率為負 103.46%，淨利潤率為 3.29%。Aveanna 更新了 2025 財年的指引。分析師的評級不一，目標價格範圍在 9.00 美元到 10.00 美元之間。近期內部人士出售了 3260 萬股，機構投資者已增加在該公司的持股</p>

<p>Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.08, FiscalAI reports. The company had revenue of $621.94 million for the quarter, compared to analysts' expectations of $578.57 million. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 103.46%. Aveanna Healthcare updated its FY 2025 guidance to EPS.</p>
<div class="lb-trans"><p>Aveanna Healthcare（納斯達克代碼：AVAH - 獲取免費報告）於週四公佈了季度財報。該公司報告本季度每股收益（EPS）為 0.15 美元，超出市場共識預期的 0.07 美元，超出幅度為 0.08 美元，FiscalAI 報道。該公司本季度的收入為 6.2194 億美元，而分析師預期為 5.7857 億美元。Aveanna Healthcare 的淨利潤率為 3.29%，股本回報率為負 103.46%。Aveanna Healthcare 更新了其 2025 財年的每股收益指引。</p>
</div><p>Get <strong>Aveanna Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
</div><h2>Aveanna Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 價格表現</h2>
</div><p>AVAH traded up $0.12 during trading on Friday, reaching $8.75. The company had a trading volume of 1,381,278 shares, compared to its average volume of 1,771,923. The company has a market cap of $1.83 billion, a P/E ratio of 24.31 and a beta of 2.04. Aveanna Healthcare has a 12 month low of $3.67 and a 12 month high of $10.32. The business's fifty day moving average price is $8.86 and its 200 day moving average price is $6.48.</p>
<div class="lb-trans"><p>週五，AVAH 的交易價格上漲 0.12 美元，達到 8.75 美元。該公司的交易量為 1,381,278 股，而其平均交易量為 1,771,923 股。該公司的市值為 18.3 億美元，市盈率為 24.31，貝塔值為 2.04。Aveanna Healthcare 的 12 個月低點為 3.67 美元，12 個月高點為 10.32 美元。該公司的 50 日移動平均價格為 8.86 美元，200 日移動平均價格為 6.48 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><p>A number of equities analysts recently weighed in on the company. UBS Group increased their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the company a &#34;neutral&#34; rating in a research report on Friday. Raymond James Financial raised Aveanna Healthcare from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $9.00 price target for the company in a research note on Monday, August 11th. Weiss Ratings reissued a &#34;hold (c)&#34; rating on shares of Aveanna Healthcare in a research report on Wednesday, October 8th. Barclays upgraded Aveanna Healthcare from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and boosted their target price for the stock from $5.50 to $9.50 in a report on Tuesday, August 19th. Finally, Royal Bank Of Canada increased their price target on Aveanna Healthcare from $8.00 to $10.00 and gave the company a &#34;sector perform&#34; rating in a report on Friday, October 24th. Three equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of &#34;Hold&#34; and a consensus price target of $10.07.</p>
<div class="lb-trans"><p>多家股票分析師最近對該公司進行了評估。瑞銀集團將 Aveanna Healthcare 的目標價從 9.00 美元上調至 9.50 美元，並在週五的研究報告中給予該公司 “中性” 評級。雷蒙德·詹姆斯金融公司將 Aveanna Healthcare 的評級從 “市場表現” 上調至 “跑贏大盤”，並在 8 月 11 日的研究報告中設定了 9.00 美元的目標價。韋斯評級在 10 月 8 日的研究報告中重新發布了對 Aveanna Healthcare 股票的 “持有（c）” 評級。巴克萊將 Aveanna Healthcare 的評級從 “等權重” 上調至 “超配”，並在 8 月 19 日的報告中將該股票的目標價從 5.50 美元上調至 9.50 美元。最後，加拿大皇家銀行在 10 月 24 日的報告中將 Aveanna Healthcare 的目標價從 8.00 美元上調至 10.00 美元，並給予該公司 “行業表現” 評級。三位股票研究分析師對該股票給予了買入評級，六位分析師給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “持有”，共識目標價為 10.07 美元。</p>
</div><p><strong>Read Our Latest Analysis on Aveanna Healthcare</strong></p>
<div class="lb-trans"><p><strong>閲讀我們對 Aveanna Healthcare 的最新分析</strong></p>
</div><h2>Insider Activity at Aveanna Healthcare</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 的內部活動</h2>
</div><p>In related news, major shareholder Robert M. Williams, Jr. sold 1,500,000 shares of the company's stock in a transaction on Friday, October 24th. The shares were sold at an average price of $9.00, for a total value of $13,500,000.00. Following the completion of the transaction, the insider directly owned 362,746 shares of the company's stock, valued at approximately $3,264,714. This represents a 80.53% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Also, major shareholder Paul R. Vigano sold 1,500,000 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider owned 362,746 shares of the company's stock, valued at approximately $3,264,714. This trade represents a 80.53% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 32,597,968 shares of company stock valued at $293,381,712. 7.80% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，主要股東 Robert M. Williams, Jr.於 10 月 24 日週五出售了 1,500,000 股公司的股票。股票以平均價格 9.00 美元出售，總價值為 13,500,000.00 美元。交易完成後，該內部人士直接持有 362,746 股公司的股票，估值約為 3,264,714 美元。這代表其持股比例減少了 80.53%。該出售在向證券交易委員會提交的文件中披露，文件可通過此鏈接訪問。此外，主要股東 Paul R. Vigano 於 10 月 24 日週五出售了 1,500,000 股股票。該股票以平均價格 9.00 美元出售，總價值為 13,500,000.00 美元。交易完成後，該內部人士持有 362,746 股公司的股票，估值約為 3,264,714 美元。這筆交易代表其持股比例減少了 80.53%。該出售的披露信息可在 SEC 文件中找到。在過去的九十天裏，內部人士已出售 32,597,968 股公司股票，價值為 293,381,712 美元。7.80% 的股票由公司內部人士持有。</p>
</div><h2>Institutional Investors Weigh In On Aveanna Healthcare</h2>
<div class="lb-trans"><h2>機構投資者對 Aveanna Healthcare 的看法</h2>
</div><p>Several hedge funds and other institutional investors have recently added to or reduced their stakes in AVAH. Vanguard Group Inc. boosted its stake in shares of Aveanna Healthcare by 34.7% during the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company's stock worth $35,850,000 after buying an additional 1,041,324 shares during the last quarter. Squarepoint Ops LLC increased its position in shares of Aveanna Healthcare by 207.0% during the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company's stock worth $2,510,000 after purchasing an additional 323,656 shares during the last quarter. Qube Research &amp; Technologies Ltd raised its stake in shares of Aveanna Healthcare by 92.4% during the 2nd quarter. Qube Research &amp; Technologies Ltd now owns 437,838 shares of the company's stock worth $2,290,000 after purchasing an additional 210,288 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at approximately $791,000. Finally, Ameriprise Financial Inc. grew its stake in shares of Aveanna Healthcare by 168.0% in the second quarter. Ameriprise Financial Inc. now owns 145,982 shares of the company's stock valued at $763,000 after buying an additional 91,508 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>幾家對沖基金和其他機構投資者最近增加或減少了對 AVAH 的持股。先鋒集團在第三季度將其在 Aveanna Healthcare 的股份增加了 34.7%。先鋒集團目前持有 4,041,659 股公司股票，價值為 35,850,000 美元，此前在上個季度又購買了 1,041,324 股。Squarepoint Ops LLC 在第二季度將其在 Aveanna Healthcare 的持股增加了 207.0%。Squarepoint Ops LLC 目前持有 479,977 股公司股票，價值為 2,510,000 美元，此前在上個季度又購買了 323,656 股。Qube Research &amp; Technologies Ltd 在第二季度將其在 Aveanna Healthcare 的持股增加了 92.4%。Qube Research &amp; Technologies Ltd 目前持有 437,838 股公司股票，價值為 2,290,000 美元，此前在上個季度又購買了 210,288 股。Lazard Asset Management LLC 在第二季度收購了 Aveanna Healthcare 的新股份，價值約為 791,000 美元。最後，Ameriprise Financial Inc.在第二季度將其在 Aveanna Healthcare 的持股增加了 168.0%。Ameriprise Financial Inc.目前持有 145,982 股公司股票，價值為 763,000 美元，此前在上個季度又購買了 91,508 股。87.96% 的股票目前由機構投資者和對沖基金持有。</p>
</div><h2>Aveanna Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.</p>
<div class="lb-trans"><p>Aveanna Healthcare Holdings Inc 是一家多元化的居家護理平台公司，在美國提供兒童和成人醫療服務。其以患者為中心的護理交付平台使患者能夠留在家中，減少對高成本護理環境（如醫院或專業護理機構）的過度使用。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦閲讀</h2>
</div><ul>
<li>Five stocks we like better than Aveanna Healthcare</li>
<li>Business Services Stocks Investing</li>
<li>e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts</li>
<li>About the Markup Calculator</li>
<li>T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?</li>
<li>Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed</li>
<li>Qualcomm Earnings Surprise Wall Street—Here’s What Q4 Could Deliver</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 Aveanna Healthcare</li>
<li>商業服務股票投資</li>
<li>分析師認為 e.l.f.的拋售是一個良好的買入時機</li>
<li>關於 Markup 計算器</li>
<li>T-Mobile 是最被低估的大型股——是買入時機嗎？</li>
<li>2022-2025 年股市假期 - 紐約證券交易所和納斯達克將何時關閉</li>
<li>高通財報讓華爾街感到驚訝——第四季度可能會帶來什麼</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=AVAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Aveanna Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Aveanna Healthcare 嗎？</h2>
</div><p>Before you consider Aveanna Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Aveanna Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄向客户推薦在更廣泛的市場注意到之前購買……而 Aveanna Healthcare 並不在名單上。</p>
</div><p>While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Aveanna Healthcare 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Aveanna Healthcare（NASDAQ 代碼：AVAH）公佈了財務業績